Lv51
1600 积分 2021-06-05 加入
[Guidelines for breastfeeding promotion strategies (2026)]
24天前
已完结
[China lymphoma diagnosis and treatment guideline (2026 edition)]
1个月前
已完结
外周T细胞淋巴瘤和NK/T细胞淋巴瘤指南的更新解读
1个月前
已完结
Ivonescimab versus pembrolizumab for PD-L1-positive non-small cell lung cancer (HARMONi-2): a randomised, double-blind, phase 3 study in China
1个月前
已完结
Ivonescimab plus chemotherapy versus tislelizumab plus chemotherapy in advanced squamous non-small-cell lung cancer (HARMONi-6): interim overall survival analysis of a randomised, double-blind, phase 3 trial in China
1个月前
已完结
Ivonescimab plus chemotherapy versus tislelizumab plus chemotherapy in advanced squamous non-small-cell lung cancer (HARMONi-6): interim overall survival analysis of a randomised, double-blind, phase 3 trial in China
1个月前
已完结
[Chinese Medical Association guideline for clinical diagnosis and treatment of lung cancer (2025 edition)]
1个月前
已完结
Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002): a randomised, double-blind, phase 3 trial
1个月前
已完结
A targeted combination therapy achieves effective pancreatic cancer regression and prevents tumor resistance
6个月前
已完结
皖公网安备34019202002308
